DESOLO – SiT peri-launch: A comparison of Symbicort Single inhaler Therapy and conventional best practice for the treatment of persistent asthma in adults
Study identifier:D5890L00011
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A comparison of Symbicort Single inhaler Therapy (Symbicort Turbuhaler 160/4.5 µg, 1 inhalation b.i.d. plus as needed) and conventional best practice for the treatment of persistent asthma in adults - a 26-week, randomised, open-label, parallel-group, multicentre study
Medical condition
asthma
Phase
Phase 3
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1600
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Dec 2004
Primary Completion Date: -
Study Completion Date: 01 May 2006
Study design
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Heinrich Worth
Klinikum Fürth
